Shilanski & Associates, Inc. Abb Vie Inc. Transaction History

Shilanski & Associates, Inc.

$296 Million
Q2 2024

A detailed history of Shilanski & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Shilanski & Associates, Inc. holds 22,639 shares of ABBV stock, worth $4.38 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

22,639

Previous 22,341 1.33%

Holding current value

$4.38 Million

Previous $4.07 Million 4.55%

% of portfolio

1.31%

Previous 1.41%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $46,127 - $53,866	298 Added 1.33%	22,639 $3.88 Million
Q1 2024 Apr 10, 2024	BUY	$159.82 - $182.1 $24,931 - $28,407	156 Added 0.7%	22,341 $4.07 Million
Q4 2023 Jan 09, 2024	BUY	$137.6 - $154.97 $14,172 - $15,961	103 Added 0.47%	22,185 $3.44 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $46,355 - $53,663	347 Added 1.6%	22,082 $3.29 Million
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $83,613 - $104,051	631 Added 2.99%	21,735 $2.93 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $30,657 - $35,306	212 Added 1.01%	21,104 $3.36 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $2.55 Million - $3.06 Million	18,449 Added 755.18%	20,892 $3.38 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $2.51 Million - $2.87 Million	-18,675 Reduced 88.43%	2,443 $328,000
Q2 2022 Aug 02, 2022	BUY	$137.62 - $174.96 $43,212 - $54,937	314 Added 1.51%	21,118 $3.23 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $53,055 - $65,827	-402 Reduced 1.9%	20,804 $3.37 Million
Q4 2021 Jan 12, 2022	SELL	$107.43 - $135.93 $28,361 - $35,885	-264 Reduced 1.23%	21,206 $2.87 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $44,262 - $50,244	416 Added 1.98%	21,470 $2.32 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $47,765 - $53,213	454 Added 2.2%	21,054 $2.37 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $102 - $112	1 Added 0.0%	20,600 $2.23 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $1.66 Million - $2.24 Million	20,599 New	20,599 $2.21 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shilanski & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shilanski & Associates, Inc. with notifications on news.

Account

Shilanski & Associates, Inc. Abb Vie Inc. Transaction History